AOXING PHARMACEUTICAL COMPANY, INC.: key financial figures for fiscal year 2016 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2016)

$32.3M

Net Income/Loss (FY2016)

$2.2M

Total Assets (FY2016)

$56.2M

Total Equity (FY2016)

$18.1M

Cash Flows from Operating Activities (FY2016)

-$535.0K

Source: AOXING PHARMACEUTICAL COMPANY, INC. 10-K filing (FY2016). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.